Renal Flashcards

(671 cards)

1
Q

Formula for clearance

A

C=(UxV)/P

Clearance
Using concentration
Urine flow rate
Plasma concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GFR

A

Clearance PAH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Filtration fraction

A

GFR/eRPF

Effective renal blood flow=effective plasma flow/fraction of blood that is plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Usually FF

A

.17-.21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Early stages of DM are associated with what

A

Glomerular hypertension/hyperfiltration. Give ACE inhibitors or angiotensin receptor blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the clearance of a solute

A

Ml/min plasma from which all of solute x has been removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

To calculate GFR we use 24 hour infusion of insulin. Why

A

Freely filtered
Not reabsorbed
Not secreted

Not endogenous molecule satisfies those conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How calculate true GFR

A

Insulin clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What must happen for clearance to exceed GFR

A

Tubular secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What endogenous chemical clearance equals the effective renal plasma flow

A

PAH (p-aminohippurate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How calculate effective renal blood flow (RBF)

A

ERPF/fraction of blood that is plasma

?????
Fraction of blood that is plasma=1-hematocrit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Filtration fraction

A

True GFR(inulin clearance)/EPRF (PAH clearance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T1/2

A

(.693 Vd)/clearance

Vd =apparent volume of distribution for the solute (I-iothalamate) freely filtered and not reabsorbed but has tubular secretion

Vd and T1/2 then allows the clearance rate to be calculated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Creatinine

A

Freely filtered, not reabsorbed but some secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Error in GFR from creatine

A

Creatinine clearance-inulin/inulin clearance ???

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why does error increase as GFR increases

A

As DFR falls the fraction of the total mass of creatinine ending in the urine decreases and more Plasma Cr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Creatine can be used to calculate GFR, but what’s thie issue with old people

A

Produce less creatine due to a decline in muscle mass—-so can remain normal despite significant decline in renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cockcroft galt forma for creatine clearance (ml/min)

A
((140-age)x(wt(kg))/
serum creatinine (mg/dL)x72) (x.85 for females)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MDRD formula for GFR

A

Takes into account race,surface area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Fraction of filtered solute that ends up in the urine

A

(VxU)/GFRxP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

If inulin concentration in infusion is doubled. What happens to

Clearance
U V

FE

A

Idk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How does glucose clearance change

A

Doesn’t
Clearance is always 0

If above issue osmotic retention and polyuria and polydipsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Clearance H20

A

V-Cosm

=-.88?????

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Free water clearance 0

Free water clearance positive

Free water clearance negative

A

Plasma osmolality=urine osmolality

Urine dilute

Urine is concentrated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How calculate daily sodium intake
Daily input=output
26
TBW white male
23-(.03age)+(.5weight)-(.62xBMI)
27
TBW black male
-18.37-(.09age)+(.34weight)+(.25height)
28
TBW white female
-10.5-(.01age)+(.2weight)+(.18height)
29
TBW black female
-16.71-(.05age)+(.22weight)+.24height Height cm and weight kg
30
Na requirement
TBWx(desired Na-serum Na)
31
Wish to raise the resum Na from 120 to 135 when TBW is 35.8. How many ml of 3% NaCl solution (513mmol/L0 would need to be infused to meet the Na requirement
1046.78
32
Fractional Excretion Na
Usually near 1% Na excreted/Na filtered= UxV/PxGFR=Cna/Ccr
33
BUN:Cr normal
10-15:1
34
Low BUN:Cr
Acute tubular necrosis (damage to kidney parenchyma so urine is more of an extracelular fluid ooze-cant concentrate)specific granite <1.01 Low protein intake Starvation Severe liver disease
35
High BUN:Cr
Pre renal acute kidney injury (small amount of concentrated urine, specific gravity >1.02) High protein intak e After GI bleed
36
Post renal AKI
Small amount of normal uring Imaging will show accumulation upstream from block Relief of obstruction can lead to post obstructive diuresis, can be life threatening Blood uring
37
24 hour protein excretion (mg/day)
UproxV Uprox(24hrUcr/Ucr)
38
Calculate 24 hour creatine. Excretion
UcrxV V=24 hr U Cr/UCr
39
Upro/Ucr
Grams/day of protein excreted
40
Microalbumin
Detect small amounts in urine (trace amounts)
41
Name thiazide diuretics (hypertension, edema)
Hydrochlorothiazide Metolazone Chlorthilidone
42
Name loop diuretics (edema, hypertension)
Furosemide Torsemide Bumetanide Ethacrynic acid
43
K sparing diuretics
Na channel blocker - amigo ride - triamterene Aldosterone antagonist - spironolactone - eplerenone
44
Aquaretics (hyponatremia
Conivaptan | Tolvaptan
45
Carbonic anhydrase inhibitor (urinary alkalinization, mountain sickness, glaucoma)
Acetazolamide
46
Osmotic diuretic (maintain uring flow, pull water from cells for excretion)
Mannitol
47
Natriuretic
Substance that promotes the renal excretion of sodium
48
Aquaretic
Substance that produces free water clearance
49
CH2O
V-Cosm V-(UosmxV/Posm)
50
Damage to any vessel branch or renal arterial vessels is a HUGE problem. Why
No arterial anastomoses Ischemia and death downstream
51
What diuretics work at the proximal tubule
Osmotic diuretics Carbonic anhydrase inhibitors
52
What diuretics work on thin descending loop of Henley
Osmotic diuretics
53
What diuretics work on thick ascending limb of henle
Loop diuretics
54
What diuretics work on distal convoluted tube
Thiazide diuretics
55
What diuretics work on cortical collecting duct
Na channel blockers spironolactone
56
What diuretics work on collecting duct
Vaptans
57
Why give diuretics
Essential hypertension Edema associatedwith - congestive heart failure - liver failure - kidney failure
58
What are K sparing diuretics and how do they work
Triamtrene, amiloride...Na channel blockers Spironolactone-aldosterone antagonist
59
Name K losing diuretics and how they work
Thiazides-Na Cl cotransporter blockers Loop diuretics-Na K 2Cl cotransporter blockers Carbonic anhydrase inhibitors (seldom used) Osmotic diuretics-non reabsorbable solutes
60
Where does mannitol work
PCT
61
Where does furosemide work
Thick segment
62
Where do thiazides work
EarlyDT
63
Where do K losing diuretics work
Early DT
64
Where do K sparing work
Late DT
65
Where do spironolactone and triamterene work
Late DCT
66
Effect of hypokalemia and hyperkalemia
Hypo-neurons don’t fire hyperpolarized Hyper-depolarizes maybe lethal since Na channels cant reactivation
67
Why are K losing diuretics and digitalis often given together to patients with CHF
Hypokalemia increases the toxicity of the digitalis
68
Heart and hyperkalemia
Tall T wave Prolonged PR interval Wide QRS interval Flattened P waves Arrhythmias including bradycardia, ventricular tachycardia or fibrillation Sinus arrest or nodal rhythm with possibl easystole
69
Hypokalemia heart
Flattened T waves ST segment depression Prolonged QT interval Tall U waves* Atrial arrhythmias Ventricular tachycardia or ventricular fibrillation
70
What diuretics have greatest amount of diuresis
Loop
71
Where do loop diuretics act
TAL
72
MOA furosemide
Inhibits reabsorption of sodium and chloride in the thick ascending limb of the loop by blocking Na K 2Cl cotransporter Inhibits paracellular reabsorption of Ca and Mg by the TAL due to loss of K backleak responsible for lumen+transepithelial potential
73
Effects furosemide
Causes increased excretion of water, sodium, K, Cl, Mg, and Ca
74
What use furosemide for
Edema, heart fail, hepatic disease, renal disease, acute pulmonary edema by decreasing preload (decrease EC vol, rapid dyspnea relief), HTN(works with low GFR)
75
SE furosemide
Hypokalemia, hyponatremia, hypocalcemia, hypomagnesia, hypochloremic metabolic alkalosis, hyperglycemia, hyperureicemia, hyperuricemia, ototoxicity (vertigo), hypersensitivity BC IT IS A SULFONAMIDE
76
Torsemide MOA
Similar to furosemide with longer T1/2 better oral absorption and some evidence that is works better in heart failure
77
Bumetadine
Sulfonamide similar to furosemide,but more predictable oral absorption ethacrynic acid: non sulfonamide loop diuretic reserved for those with sulfa allergy
78
Clinical effect of furosemide
Max doses_>profound diuresis! From dissatisfaction of the medullary interstitial gradient —irrespective of whether urine was dilute or concentrated, get large volume of isotonic urine
79
How give furosemide
PO, IV, IM IV 5 min last 2 hours PO 30-60 min lasts 8 hours
80
When prescribe furosemide
When rapid and massive fluid removal is needed (edema, cardiac, renal origin), acute pulmonary edema, HTN that is unresponsive to other diuretics (still works with RBF and GFR are low)
81
Furosemide and acute pulmonary edema
Rapid effects <5min that are though to be due to prostagladin mediated venodilaion that reduces preload
82
SE furosemide
HypoNa, hypoCl, hypoK, which lead to hypovolemia and hypotension HypoMg HypoCa
83
Furosemide as a K losing diuretic causing hypoCl metabolic acidosis
K H exchange at cells try to maintain plasma K Also Na K exchange
84
Risk of hypoCa and furosemide
Kidney stones (OPPOSITE OF THIAZides
85
Ototoxicity of furosemide
Hyperglycemia Hyperuricemia (gout) Decrease HDL, increase LDL, increase TG (atherosclerosis
86
Preg and furosemide
NO
87
Digoxin and loop diuretics
Frequent interactions since both drugs are often used to treat heart failure and the risk of digoxin toxicity is increased by low K due to the diuretic
88
Ototoxicity drugs and loop diuretics
Increased chance of hearing loss if combined with drugs having similar toxicity
89
Potassium sparing diuretics and loop diuretics
Can counterbalance potassium wasting effects
90
Loop diuretics other drug interactions
Lithium toxicity, potentialte effects of other antihypertensive agents and have diuretic effects antagonized by NSAIDS
91
Bumetanide
More predictable absorption
92
Toresimide
Long T1/2 better for absorption, may work better in heart failure
93
Ethacrynic acid*
Among the few diuretics that can be used by people who are allergic to sulfa drugs
94
Loop diuretics cause the largest Na loss, are K losing, and cause similar __ loss than either loop of K sparing diuretics
HCO3
95
Thiazide diuretics most used
Hydrochlorothiazide-sulfa drug 12 others often ending in thiazide
96
Where do thiazides work
early DCT
97
MOA hydrochlorothiazide
Inhibitors Na reabsorption in the DT via blockade of NaCl cotransporter
98
Effects of hydrochlorothiazide
Increases urinary excretion of Na and H2O Increases urinary excretion of K and Mg K losing
99
Clinical use of hydrochlorothiazide
HTN (not effective in patients with low GFR) Edema Calcium nephorlithiasis
100
SE hydrochlorothiazide
Orthostatis hypotension Hypo k, mg, na, cl, metabolic alkalosis Hyper ca, hyperglycemia, hyperuricemia Sulfa-hypersensitivity
101
Chlorothiazide
Similar to HCTZ but poor oral absorption
102
Chlorthaliodne
Similar to HCTZ but half life of f40-60 hrs..prolonged/stable response with proven benefits is reason it is preferred by some hypertension specialists
103
Metolazone
Another long acting thiazide diuretic, this’s is a favorite of cardiologists for use as an adjunct diuretic in the treatment of CHF
104
MOA thiazide
Block Na Cl cotransporter More Ca reabsorption in PT bc of volume contraction Mg only reabsorbed in TALH.distal nephron ...loss greater with thiazides than loop diuretics
105
Location of thiazide diuretics means its diuresis _ with loop diuretics, _ downstream acting K sparing diuretics
< | >
106
THIAZides and low GFR and RBF
Don’t work
107
THIAZides cause the greater __ loss. Implications?
HCO3 Impairs distal nephron H secretion
108
Pharmacokinetics thiazide
Diuresis begins < 2 hours after oral ingestion with peak at 406 hours and effects lasting 12 hours.. in other works shouldn’t take this one at bedtime Drug is exceed unchanged in uring
109
Uses of thiazide diuretics
primary HTN and edema Nephrotoxicity diabetes insipidus Decreases Ca excretion, day decraese risk of kidney stones (opposite of loop diuretics( Can be added to loop diuretics to increase diuresis
110
Adverse effects thiazides
Hypovolemia K losing (downstream Na K exchanger tried to salvage Na at hte expense of K) Hypochloremic metabolic alkalosis Hypomagnesia
111
Drug interactions thiazide
Combined with antiHTN meds K loss can be offset by combining K sparing diuretics Increase risk of digoxin and lithium toxicity
112
Chlorthalidone
1-2 x more potent Different structure Longer HL Larger volume of distribution than HCTX, prescribed much less commonly in the US
113
Doses of thiazide 12.5-25
Reduce CVD mortality and morbidity
114
THIAZides are intermediate with _ loss, are _ losing, and cause larger _ lossdue to inhibtion of distal H secretion
Na K HCO3
115
Where does spironolactone act
Cortical collecting duct
116
K sparing diuretics
Triamterene, amiloride..Na channel block | Spironolactone..aldosterone antagonist
117
MOA amiloride
Blocks the luminal Na channels in CT
118
MOA spironolactone
Blocks aldosterone receptor in CD
119
Effects amiloride
Small increase in Na excretion Blocks major pathway for K elimination so K is retained H Mg Ca excretion also decreased
120
Clinical applications amiloride
Counteracts K loss induced by other diuretics in the treatment of HTN or heart failure Ascites, pediatric HTN
121
SE amiloride
``` Hyper K Hypo Na Hypo vol HyperCl metabolic acidosis Dizzy, fatigue, headache ``` Nauseas vom
122
Triamterene
Similar to amiloride for edema and off label HTN rapidly absorbed, duration of 6-9 hrs, eliminated as drug metabolites
123
Spironolactone MOA
Competitive antagonist of aldosterone receptors Partial agonist at androgen receptors
124
Effects of spironolactone
K sparing
125
Clinical applications spironolactone
Counteracts K loss induced by other diuretics in the treat of HTN, heart failure, ascites Hyperaldosteronism Reduce fibrosis post MI Hirsutism
126
SE spironolactone
HyperK Amenorrhea, hirsutism, gynecomastia, impotence
127
Eplerenone
More selective aldosterone antagonist, approved for use in post MI heart failure and alone or in combination for HTN
128
Amiloride and triamterene _ urinary Na excretion and _ unitary K excretion
Increase Decrease If Na cant get into the cell, K cant get out of the cell into the tubular lumen
129
Pharmacokinetics amiloride triamterene
Channel is blocked directly, effects are seen more rapidly than with spironolactone but smaller and therefore harder to detects lasts 12-16 hours
130
Uses of triamtene
HTN, edema, often in combo with loop of thiazide diuretic
131
Adverse effects K sparing
Hyperkalemia | Nausea, vom, leg cramps, dizzy, bloody dyscrasias rare
132
MOA spironolactone
Blocks ability of aldosterone to bind to its receptor and increase Nareabsorption int he CCD Leads to increased Na accretion
133
Pharmacokinetics spironolactone
Can take 48 hours to work Steroid hormones produce effects with a slow onset
134
Uses spironolactone
HTN and edema, often in combination with a loop or thiazide diuretic Primary hyperaldosteronism Reduce mortality rate in patients with severe heart failure
135
SE spironolactone
HyperK, endocrine effects include gynecomastia, importance’s, menstrual irregularities, hirsutism and deepening voice
136
Drug interactions spironolactone
Often combined with thiazide and loop diuretics to counteract their K loss Should NEVER be given with drugs that increase plasma potassium levels, but used cautiously with ACE inhibtiors
137
Amiloride/triamtere and spironolactone are _ sparing and cause the smallest _ loss while causing _ excretion to fall below normal. They also cause significant __ loss by interfering with distal H secretion
K Na HCO3
138
Where do vaptans work
CD
139
MOA vaptans
Block antidiuretic hormone receptor in the CD
140
MOA conivaptan
Non peptide arginine vasopressin receptor antagonist V1A and V2
141
Effects conivaptan
Promotes excretion of free water Decreasing Uosm Increasing Posm
142
Clinical applications conivaptan
Euvolemic and hypervolemic hyponatremia in patients that are hospitalized, symptomatic, not responsive to fluid restriction
143
Why monitor plasma sodium and nuerological status in conivaptan
Too rapid serum sodium correction can lead to seizures, osmotic demyelination, coma, or death
144
SE conivaptan
Orthostatic hypotension, fatigue, thirst | Polyuria, bedwetting
145
Tolvaptan
Selective V2 receptor antagonist given ORALLY Initiate and reinitiate tolvaptan in patients ONLY IN A HOSPITAL where plasma sodium can be closely monitored Must use <30 days for hyponatremia, longer use can kill by hepatoxicity
146
MOA conivaptan and tolvaptan
Prevents ADH mediated insertion of the aquaporin water channels into luminal membrane of principle cells in collecting duct Prevents the reabsorption of water, therefore increases water excretion Decrease plasma volume and increase plasma osmolality primarily due to an increase in plasma sodium
147
Pharmacokinetics conivaptan and tolvaptan
Conivaptan-t1/2 5.3-8.1 hours Tolvaptan effects increase to peak at 4 hrs, lasts 4-8hours
148
Uses of vaptans
Hypervolemic or euvolemic hyponatremia AD polycystic kidney disease
149
SE vaptans
Orthostatic hypotension Fatugue Thirst Polyuria, bedwetting
150
Drug interactions vaptans
Metabolized by CYP3A4, so inhibitors and inducers of this enzyme can alter its half life and potential for toxicity Selective water loss means - possibility of hypovolemia - other electrolytes and drugs can become concentrated..hyperNa, K uricemia Toxic levels
151
Where do carbonic anhydrase inhibitors act
PT
152
Where do osmotic diuretics act
Tin descending limb
153
Main carbonic anhydrase inhibitor
Acetazolamide-sulfa drug Causes metabolic acidosis and alkaline urine
154
MOA carbonic anhydrase inhibitors
Na bicarbonate diuresis Bicarbonate remains in early proximal tubule H cyclone lose, inhibiting Na/H exchange Hyperchloremic acidossi
155
Uses of carbonic anhydrase inhibtiors
Urinary alkalinization Metabolic alkalosis Glaucoma:acetazolamide, dorzalamide Acut mountain sickness
156
Adverse effects carbonic anhydrase inhibitors
Hyperchloremic metabolic acidosis Nephrolithiasis: renal stones Potassium wasting
157
Main osmotic diuretic
Mannitol Also use urea, glycerin and isosorbide
158
MOA mannitol
Non metabolized 6 carbon sugar, freely filtered with minimal reabsorption The inability to reabsorbed. This keeps water water in the proximal tubular lumen; this water is delivered to the distal portions of the nephron where much of it is excreted Pull water out of cells Excrete TBW in excess of plasma electrolytes
159
Pharmacokinetics mannitol
Distributes in ECF, must give IV large amounts 50-2000 g Effects are noticeable within 30-60 minutes and mannitol is eliminated unchanged in the urin over a period of 6-8 hours
160
SE mannitol
EC volume is acutely increased bc mannitol sucks water out of the cells which can exacerbate heart failure Headache, nausea, vomiting and fluid electrolyte imbalances also occur
161
Uses of mannitol
Prophylaxis of renal failure Reduction of intracranial pressure Reduction of intraocular pressure
162
Carbonic anhydrase causes _ Na excretion _ K and _ Hco3
Some more MOST
163
Osmotic diuretics cause _ Na, _ K _ KCO3 excretion
More, smoke,some
164
Herbal diuretics
Many souls ith claims that they are effective Some can Probably OK by themselves BUT DO NOT MIC WITH CONVENTIONAL DIURETICS bc of potential for adverse effects
165
Licorice
Contains sweet glycyrrhizic acid , potentials aldosterone effects in kidney and dose-dependently increases systolic blood pressure
166
Treat renal insufficiency or nephrotic syndrome
Loop diuretic Add thiazide according to ClCr Add distal diuretic
167
Treat cirrhosis
Spironolactone ClCr >50 add HCTZ ClCr<50 do to loop diuretic and treat like renal insuff or nephrotic syndrome
168
Treat CHF
Treat like renal insufficiency or nephrotic syndrome if not mild Mild and ClCr <50 treat like “” Mild and ClCr>50 add HCTZ then treat like rest
169
Causes of diuretic resistance
Incorrect diagnosis (venous or lymphatic edema) Inappropriate NaCl or fluid intake ) Inadequate drug reaching tubule lumen in active form -poor absorption (uncompensated HF) -decreased RBF (HF, cirrhosis, old) Decreased functional renal mass (AKI, CKD, old Inadequate renal response -low GFR (AKI, CKD) , decreased effective arterial volume (edema) -activation RAAS (edema -nephron adaptation (prolonged diuretic therapy -NSAIDS(indomethacin, asprin
170
How lower bp
Thiazide diuretics, furosemide, K sparring diuretics
171
Treat HTN
ACE I or ARB or CCB not black Black thiazide
172
Diuretics for heart failure
Stage C-HF Diuretics to relieve congestion Aldosterone antagonists
173
Diabetes insipidus
Excesssice passing of urine , tasteless Central-lack of ADH Can treat with ADH agonist Nephrogenic-unresonveness to ADH Treat with thiazide diuretic
174
Treat diabetes insipidus
Desmopressin, a synthetic V2 agonist if central If lack of ADH response frominterstitial fibrosis, Li, antagonism of ADH in principal cells Thiazide diuretics
175
___ is the most common cause of nephrogenic DI
Appearance of DI symptoms in this case coincides with use of Li to treat bipolar disorder
176
Thiazide diuretics are contraindicated in ___
Li induced DI bc Li reabsorption-like Na reabsorption is increased in the proximal tubule and can cause Li toxicity
177
How treat Li induced diabetes insipidus
Amiloride..blocks influx of Li into CCD cells Very dilute urine->urine of appropriate concentration to maintain water homeostasis bc amiloride blocks Li influx into principal cells, allowing ADH to work
178
THIAZides treat nephrogenic diabetes insipidus IF
It is NOT caused by lithium
179
If Li causes nephrogenic DI (from bipolar treatment), _____ is the treatment
Amiloride
180
Describe the distribution of calcium in the body
Plasma least, more intracellularly, most IN THE BONE
181
Why is it important to control Ca within a narrow range
Muscle contraction Intracellular signaling Bone formation Neuronal excitation
182
Effects of hyper and hypocalcemia
Hyper-raise threshold Hypo-lowers threshold
183
How does hypoalbuminia effect calcium. What are the implications
Decreases total serum calcium without affecting ionized. If serum albumin is abnormal, clinical decisions should be based on ionized calcium levels
184
Corrected calcium
Measured total Ca (mg/dL)+.8 (4-serum albumin )
185
Hormones that control calcium
Calcitrion (1,25 OH vitamin D3) PTH Calcitonin Sites of regulation—-kidney, bone, intestine
186
Effects of calcitonin
Lowers blood Ca levels in three ways: -inhibits Ca absorption by the intestines -inhibits osteoclast activity in bones -inhibits renal tubular reabsorption of Ca (increase Ca excretion) Like PTH it inhibits tubular phosphate reabsorption
187
Effects of PTH
Increase plasma Ca, decrease plasma PO4–>increased ionized plasma Ca - acts in distal nephron to increase Ca reabsorption - inhibits PO4 reabsorption int he proximal tubule - enhances bone release of Ca
188
What controls secretion of PTH
Serum Ca acting on calcium sensing receptors on Parathyroid cells in a negative feedback manner Activated by low Ca
189
Calcitrion (1,25-OH D3)
Renal synthesis from 25-OH vitamin D3 is stimulated by PTH Acts through calcitrion receptor Increases blood Ca levels
190
How does calcitrion (VD3) increase Ca levels
Promotes absorption of dietary calcium from GI tract Increases renal tubular reabsorption of filtered Ca Stimulates release of Ca from bones...acts on osteoblasts to activate osteoclasts
191
__ of filtered calcium is reabsorbed in the PT. How
65 Paracellular, but some active transport
192
The thick ascending limb of loop henle has lumen positive voltage that drives ____ Ca reabsorption of __%
Paracellular | 20
193
Distal tubule is site of _% of calcium reabsorption but major site of regulation. How
8 Active transport along electrical and chemical gradients Renal epithelial Ca channel(TRPV5)-along with calbindin, regulated by calcitriol
194
Calcium reabsorption is _ in CD
5%
195
Klotho
Enzyme that can break down complex carbs, disruption leads to premature aging...has a direct stimulators effect on TRPV5
196
How is conductance of TRPV5 regulated
PTH and locally synthesized tissue kallikrein
197
Calbindin-D28K and TRPV5 expression is regulated by __
Vitamin D
198
What is the response to hypercalcemia
Decreased Ca absorption Increased Caexcretion Decrease bone resorption NORMOCALCEMIA
199
Causes of hypercalcemia
*entry of calcium into ECF by bone resorption and intestinal absorption Primary hyperparathyroidism, thiazide diuretics, milk alkali syndrome, familial hypocalciuric hypercalcemia, malignancy, immobilization syndrome, granulomatous disease, VD intoxication
200
Clinical features of hypercalcemia
Mild-asymptomatic Severe-neurologic (weak, fatigue, confusion, stupor, coma) and GI (anorexia, nausea, vomiting and constipation) NV cause hypovolemia —impaired calcium excretion—worsening
201
How manage acute hypercalcemia
Increasing calcium excretion Decreasing resorption Decreasing absorption —-ECF volume replacement with .9% saline ——furosemide —-calcitonin
202
What give if hypercalcemia not responding to saline diuresis, and espicially if secondary to malignancy
Bisphosponates
203
Causes of hypocalcemia
Decreased calcium absorption from GI or decreased resorption Hypoparatyroidism, chronic kidney disease,familial hypocalcemia, rhabdomyolysis, septic shock, VD defiency, parathyroidectomy, acute pancreatitis (Ca soaps)
204
What is true hypocalcemia
When ionized calcium concentration is reduced
205
Hypocalcemia clinical feature
Neuromuscular irritability (fatigue, paresthesia, circumpolar, twitching, tetany, chvostek, trousseau, laryngeal and bronchial spasm) Altered central nervous system function (emotional disturbances, depression, coma, seizures, papilledema, cerebral calcifications) CVD (lengthen QT, dysrhythmias, hypotension, CHF) Derm(dry skin, coarse hair, brittle nails, cataracts)
206
How manage hypocalcemia (seizures, tetany, hypotension or cardiac arrhythmias)
IV calcium
207
How manage chronic mild hypocalcemia
Oral calcium supplements +/- VD
208
How treat hypocalcemia with hypoparathyroidism
Calcium and VD supplements
209
Why need phosphorus
Bone formation, cellular energy metabolism, regulation of protein/enzyme function
210
Describe body distribution of phosphorus
85% bone rest in cells 1% ECF 2/3 organic phosphate 1/3 inorganic
211
What increases serum phosphate
Decrease by carbohydrate or glucose infusion Increase by high phosphate meal
212
Effect of PTH on PO43
Decreases serum by increases renal excretion
213
FGF-23 effect on PO43
Decreases serum PO4 by increases renal excretion
214
1,25 (OH)2D3 effect on phosphorus
Increase serum PO4s..increases intestinal phosphate absorption
215
Insulin effect on phosphate
Decrease serum PO43..shirt phosphate into cells
216
What is FGF-23
Phosphatonin released by bone that promote PO43 excretion by the kidney...familial problems also can be secreted by tumor to cause phosphate wasting
217
The dietary intake is 900 mg/day
70kg man filters 200 molecules PO42 per day with 12.5 excreted int he urine - contrast with 1% of filtered Na excreted in urine - corresponds to 900 mg/day or 64% of dietary intake/day that needs to be laminated by kidneys Becomes problematic when GFR falls
218
PhosphorusReabsorption..55-85% is reabsorbed in PCT
3 Na dependent PO43 transporters NaPi2 is responsible for 85% transport, highly regulated FGF-23 and PTH regulate
219
In the kidney phosphorus is regulated by what
PTH and FGF-23
220
Causes of hyperphosphatemia: decreases renal excretion of phosphorus
Chronic kidney disease stages 3-5 Acute renal failure/acute kidney injury Hypoparathyroidism, pseudohypoparathyroidism Acromegaly Tumoral calcinosis FGF-23 inactivating gene mutation GALNT3 mutation with aberrant FGF-23 glycosylation KLOTHO inactivating mutation with FGF-23 resistance Bisphosphonatesc
221
Causes of hypophosphatemia:exogenous phosphorus administration
Ingestion of phosphate, phosphate-containing enemas IV phosphate delivery
222
Redistribution of phosphorus : causes of hyperphosphatemia
``` Respiratoy acidosis/metabolism acidosis Tumor lysis syndrome Rhabdomylosis Hemolytic anemia Catabolic state ```
223
Causes of hyperphosphatemia: pseudohperphosphatemia
Hyperglobulinemia, hyperlipidemia, hemolysis, hyperbilirubinemia
224
Clinical features of hyperphosphatemia
Deposition of Calvclium in soft tissues and resultant fall in ECF ionized calcium Calciphylaxis
225
Chronic hyperphosphatemia causes what
Renal osteodystrophy
226
How manage hyperphosphatemia
Acute-saline diuresis | End stage kidney disease-reduce dietary intake/intestinal absorption (phosphate binder)
227
Describe secondary hyperparathyroidism in CKD
CKD causes decreased 1,25 (OH)2D3 and increased phosphorus causing decreased calcium and increased FGF-23...increases PTH Both FGF-23 and PTH are phosphatic
228
Renal osteodystrophy
Bone demineralization due to chronic kidney disease Can cause bonejoint pain, bone deformation or fracture
229
What causes renal osteodystrophy
Hyperparathyroidism secondary to hyperphosphatemia...kidney is unable to excrete phosphate
230
Renal osteodystrophy combined with hypocalcemia
Kidney unable to activate vitamin D to calcitrion needed for Ca absorption from diet
231
Treat renal osteodystrophy
Ca/VD supplement Restriction of dietary phosphate, use of phosphate binders Hemodialysis/renal transplantation China cal et (calcium sensitized drug, lowers PTH)
232
What may cause hypophosphatemia
Redistribution of extracellular phosphate into the intracellular space Decrease in intestinal absorption of phosphate Decrease in renal reabsorption of phosphate
233
Re-feeding hypophosphatemia
Can be cause of death in starving people/anorexics as hexokinase phosphorylation glucose taken into cells
234
Alcohol related hypophosphatemia
Tend to be malnourished so re feeding syndrome partially responsible
235
Diabetes mellitus hypophosphatemia
When treated with large doses of insulin
236
Urinary loss causing hypophosphatemia
Faccini
237
Oncogene osteomalacia causing hypophosphatemia
Tumor makin FGF23
238
Clinical signs of hypophosphatemia (occur only if total body phosphate depletion is present)
Muscular abnormalities-weak, rhabdomyolysis, impaired diaphragmatic function, respiratory failure, heart failure Neurologic abnosmalities-paresthesia, confusion, stupor, dysarthria, seizures, and coma Hemolysis and platelet dysfunction Chronic hypophosphatemia-rickets, in kids, stromal Asia in adults
239
Manage moderate hyphosphatemia
Asymptomatic and requires no therapy except treatment of the underlying cause
240
Manage persistent hypophosphatemia
Oral phosphate
241
Manage severe hypophosphatemia
IV phosphate therapy espicially when associated with serious clinical manifestations
242
Hypophosphatemia patients frequently are also hypo____ and hypo__ and these disorders must also be corrected
Kalemic | Magnesemic
243
Describe distribution of Mg
50% mineralized in bone 49% intracellularly 10% ionized but has crucial role as cofactors in many biological processes such as ATPases, regulation of ion channels and translational processes 1% extracellular with 60% of that ionized , 30% bound albumin, 10% complexed with phosphatase
244
15% of Mg is reabsorbed in the PCT> how
Paracellular and follows Na
245
70% of Mg is reabsorbed in the TAL. How
Driven by the transepithelial gradient generated by Na K 2Cl cotransporter
246
10% of Mg is reabsorbed in DCT. How
Via TRPM6 channels
247
Why is Mg absorption unique
PCT not major site of reabsorption
248
Describe Mg reabsorption in DCT
Mg concentration same inside and outside, so electrical potential is primary driver of cellular Mg influx, intracellular shuttling is not well understood Hormonal regulation is uncertain and thought to be indirect, EGF is only hormone identified thus far
249
_% of ICU patients have hypomagnesemia
60
250
What causes hypomagnesia in ICU patients
Decreased nutrition, diuretics, decreased albumin, aminoglycosides, decreased reabsorption (PPI)
251
Common causes of Mg defiency
Alcoholism, malabsorption, parenteral nutrition, PPI, familial hypomagnesia with secondary hypocalcemia Increased losses Redistribution -hungry bone syndrome
252
Clinical signs of hypomagnesia
Neuromuscular manifestations(weak, tremor, seizures, tetany, positive chvostek and trousseau (but think Ca first), nystagmus CVD-T wave changes, U waves, prolonged QT and QU, repolarized alternans, premature ventricular contractions, v fib, monomorphic ventricular tachycardia, enhanced digitalis toxicity) Metabolic-hypoK and Ca
253
Treat hypomagnesia
Oral or IV Mg
254
When is hypermagnesia seen
End stage renal disease Massive intake..epsom salt Magnesium infusion..administration to limit neuromuscular excitability in pregnant women with pre-ecclampsia/ecclampsia
255
Clinical signs of hypermagnesemia
<3.6 asymptomatic 4. 8-7.2-nauseas flushing headache 7. 2 to 12 somnolence, hypoca, absent DTR, hypotension, bradycardia >12 -muscle paralysis-flaccid
256
Treat hypermagnesemia
Normal renal function-stop administration and wait and/or add loop or thiazide diuretic Reduced renal function -stop administration and wait and/or add loop thiazide diuretic then ADD SALINE End stage kidney disease-dialysis
257
With hypertension why do expel feel better when not taking meds
Side effects
258
Risk of HTN
``` Family history Age Males Black Diabetes ```
259
Primary HTN
92%, no cause found, chronic and progressice, use drugs that lower BP but DONT treat underlying cause Low renin Normal renin High renin
260
Secondary HTN
Primary cause identified, less, can be cured by treating cause
261
Causes of secondary HTN
``` Chronic kidney disease Renovascular OC Coarctation Primary aldosteronism Cushing ```
262
Calculate arterial pressure
COxperipheral resistance
263
Resistance formula
8nl/pir^4 N-viscosity L length R radius
264
Sympathetic baroreceptor reflex
Reflex circuit keeps arterial pressure at present level on a second by second basis
265
How does the sympathetic baroreceptor reflex “sense”
Stretch receptors located in the carotid sinus and aortic arch
266
What happens when sympathic baroreceptor reflex is opposed
Attempts to reduce arterial reassure with drugs Innervated the heart and travel along the blood vessels, forming multiple synapses such that the nerves resemble a string of beads
267
A1 adrenergic receptor
On bc to cause vasoconstriction to maintain venous return with changes in posture
268
A2 adrenergic receptors
Act both in the brain and in the periphery in a presynaptic receptors act in both the brain and in their periphery in a presympathetic tone
269
B1 adrenergic receptors
Increase heart rate and contractility, and stimulate renin secretions by the kidneys
270
B2 adrenergic receptors
Dilate skeletal muscle vasculature | -important during fight or flight response with concomitant a1 receptor vasoconstriction blood shunted to msucles
271
What is the ultimate regulator of blood pressure
Renal blood volume, it is slow! But keep in mine, high salt intake causes hormonal changes that shift the intrinsic renal relationship between arterial pressure and urinary output of Na to the left, low salt to the right
272
In HTN, the blood pressure set point is resent to a higher level, but can be either salt resistant or salt sensitive
Salt resistant, not changes in slope but increases Salt sensitive, bo up in dose response
273
Drugs for lowering bp
Vascular smooth muscle Vascular a1 receptors Renal tubules (B1 juxtagloerular cells, angiotensin converting enzyme, angiotensin II receptors, aldosterone receptors) Brainstem Sympathetic ganglia Adrenergic terminals Cardiac B1 receptors
274
Hypertension drugs
Thiazide diuretics, ACEI or ARB, and CCB
275
Why are B blockersnow generally limited to other compelling indications
Do not prevent MI, heart failure, or death as well as other therapies Associated with a significantly higher incidence of stroke than other therapies
276
Describe RAAS
Angiotensin I cleaved from angiotensinogen by renin is cleaved by angiotensin converting enzyme to form angiotensin II.
277
Effects and angiotensin II
Vasoconstrictor, increases total peripheral resistance Acts to increase extracelllular fluid volume - stimulating thirst - stimulating aldosterone secretion - stimulating ADH secretion
278
Why get increase in TPR in chronic hypertension
Follow an initial increase in cardiac output In some cases TPR increase is initiating event
279
Why is hypertensive vascular remodeling reduced by ACEI or ARB and CCB
Idk
280
Lifestyle modifications for essential hypertension
Weight reduction Na restriction Alcohol restriction Exercise Smoking cessation Maintence of K and Ca intake Stress management
281
What drugs affect the angiotensin II formation or action
Aliskirin ARBS ACEI
282
How does RAAS inhibition effect kidney
Serum creatinine increases (preserves kidney function in hyperfiltering diabetics, can also alarm. Physicians) Ang II tone helps maintain resistance in efferent arterioles
283
MOA captopril
Competitive inhibitor of ACE
284
Effects of captopril
Prevents conversion of angiotensin I to II Lowers levels of angiotensin II Increase renin and decrease aldosterone Lowers bp
285
Clinical application captopril
Hypertension, add thiazide or loop diuretic if additional lowering is needed at max recommended dose Acute HTN HF with reduced ejection fraction LV dysfunction following MI Diabetic nephropathy
286
SE captopril
Cough Angioedema Hypotension Headache
287
Enalapril
Another early ACEI, a prodrug with active form available for IV
288
Benzapril
ACE inhibitor, longer half life permitting 1 dose a day
289
Lisonopril
Now widely used ACE inhibitor, longer half life permitting 1 dose a day
290
What is the main reason to stop taking ACE inhibitor
Cough
291
Deadly side effect of ACE inhibitor
Angioedema can be deadly CHOKE AND SWALLOW ON OWN TONGUE
292
Losartan MOA
Competitive nonpeptide angiotensin II receptor antagonist for AT1
293
Effects of losartan
Blocks vasoconstrictor and aldosterone-secreting effects of angiotensin II Induces a more complete inhibition of the renin angiotensin system than ACE inhibitors Does not affect the response to bradykinin
294
Clinical applications of losartan
Treatment of diabetic nephropathy with increased Scr and proteinuria in type 2 diabetes and HT HT, Akon or in combination with other antihypertensives Hypertension with left ventricular hypertrophy to reduce risk of stroke CKD and HT regardless of race or diabetes status, to improve kidney outcomes Heart failure if intolerant of ACE inhibtiors Off label Marian
295
SE losartan
More common in diabetic nephropathy Hypotension, first dose hypotension, orthostatic hypotension Fatigue, dizzy Hypoglycemia, hyperkalemia Diarrhea, gastritis, nausea, weight gain Anemia Weakness, back/knee Cough
296
Valsartan
T1/2 6-10 hrs, noteworthy in that not a prodrug requiring activation, excreted primarily in feces as unchanged drug
297
Candesartal
T1/2 is 5-9 hrs, noteworthy for its relatively irreversible binding
298
Aliskiren MOA
Direct renin inhibitor, resulting in black of the conversion of angiotensinogen to angiotensin I
299
Effects aliskiren
Decreases the formation fo angiotensin II, a potent blood pressure elevating peptide elevating peptide viavasoconstriction, aldosterone release and Na retention ACE inhibitor and ARB therapy can be offset by increases in plasma renin activity (PRA), which is blocked by direct renin inhibitors
300
Clinical applications aliskiren
Treatment of HTN alone or in combination with other antihypertensive agents
301
SE aliskiren
Few Rash Cough Diarrhea
302
Rout of aliskiren
2 weeks see effects | T1/2=24hrs
303
What should new drug for HTN be based on
Age, race, Conor I’d conditions
304
Asthwhen should you not use a drug like B blocker like propranolol
Asthma B2 agonists are used for bronchodilator Diabetes..B2 receptor effects offset hypoglycemia and alert patient via palpitations
305
When should you not use calcium channel blockers for HTN
Heart failure
306
Blacks health problems
HTN at earlier age Average bp higher Worse disease severity More stroke, heart disease, and stage KIDNEY disease, heart failure
307
__, ___ and ___ are less effective as monotherapy than in whites but __ and ___ work well
B blockers, ACE inhibitors and ARBS Diuretics , calcium channel blockers
308
B blockers, ace inhibitors and ARBS work well when added with a
Diuretic Should be used first line combinations herapy if SBP>15 and DBP>10
309
Secondary HTN is more common in kids, what do
Identify cause and treat
310
Do not give _ or _ to sexually active girls
ACE inhibitors ARBS
311
What can angII decrease cause
Efferent tone Precipitate renal failure in patients with bilateral renal stenosis Can help preserve renal function in diabetic patients
312
ACEI contraindication
Pregnancy | All trimesters
313
Manifestations of renal artery stenosis
Asymptomatic incidental RAS Renovascular hypertension Accelerated CV disease CHF, stroke, scndoary aldosteronism Ischemic nephropathy
314
Appearance of what suggests bilateral renovascular hypertension rather than primary hypertension
Flash pulmonary edema, progressive renal failure, refractory congestive cardiac failure
315
Essential HTN vs renovascular HTN
Renovascular has more abdominal bruit, blood urea, potassium, duration, urinary casts and proteinuriia
316
Effect of bilateral renal stenosis
Reduced renal perfusion Increase RAAS, impaired Na and water excretion ->volume exmpasion inhibitors RAAS Overall-reduced arterial pressure only after volume depletion may lower GFR Detect with renin plasma
317
Unilateral renal artery stenosis block of RAS
Reduced arterial pressures Enhanced lateralization of diagnostic tests GFR fallelevated plasma renin
318
Systemic effects of increased renin due to stenosis
Vasoconstriction, Na retention, aldosterone secretion, vascular, sympathetic nervous system, Myocardial effects
319
How treat renal stenosis
Not surgery it fails to materially recover kidney function Use drugs to block the RAAS and statin therapy
320
Red urine
Hematuria
321
Cloudy urine
Pyuria +/- bacteria
322
Beeturia
Rhubarb and blueberries
323
Green urine
Asparagus
324
Blue urine
Methylene blue in viagara
325
Yellow urine
Riboflavin (BIRGHT yellow)-can be used to turn it yellow if drinking a lot of water to pass a drug test
326
Defiency branched chain alpha keto acid dehydrogenase (BCKDC)
AR maple syrup I urine disease Buildup of branched chain aa (leucine, isoleucine, valine) and their toxicity by products (ketoacidosis) in the blood and the urine unless dietary intake is carefully managed
327
Everyone has smelly pee after asparagus due to breakdown of sulfurous aa into volatile/odorous compounds Only a fraction can smell
Woah
328
Sweet smell and taste or urine or see if it attract ants
DM
329
Smell of urine with UTI and/or kidney stones
Fishy
330
Specific gravity low urine (normal 1.01-1.025) What does 1.025 mean
DI Glomerulonephritis Pyelonephritis Can’t concentrate urine Highly concentrated
331
Normal pH of urine
6 ——fixed acid is being excreted as ammonium
332
What does a negative reading for urine dipstick leukocytes indicate
A high power field likely has 3-5 neutrophils
333
Brown urine, dipstick positive for blood, no RBC visible by microscopy
``` MYOGLOBINURIA Intravascular hemolysis Nephrotic syndrome Urine contains a dye Nephrotic syndrome Analgesi nephropathy ```
334
Positive nitrate urine test?
Gram negative organism?
335
50 for urine ketones
Diabetic ketoacidosis
336
Bilirubin in urine
Liver disease
337
Urobilinogen in urine
Hemolytic disease
338
Protein over 1000 in urine
Nephrotic
339
Foamy urine suggesting protein but protein negative and sulfasalicylic acid test indicates presence of protein
Bcence Johnson protein in multiple myeloma
340
Urine over 100 mg/dL glucose
Filtered load of glucose is greater than PCT reabsorption capacity
341
Triple phosphate crystals (struvite) in either common form (coffin lid) or rapidly precipitated form, ammonium urate crystals Calcium phosphate crystals Amorphous phosphates
Urine infected with ammonia producing organisms ALKALINE
342
System needs, tyrosine, and leucine in urine Cystine crystals (hexagon) tyrosine cryastals (fine delicate needles), calcium oxalate crystals (enveloped), uric acid footballs), sodium irate, sulfonamide crystals (antibiotics), amorphous-specs(urate)
Acidic urine Metabolic origin
343
Urine casts
Damage to the glomerular endothelial cells Form when the tubule cells die and slough off WBC casts form HTN there is tubulointerstitla nephritis
344
Tamm horsfall protein
Encase/lubricate junk in the tubular lumen to facilitate elimination Keep distal tubules from collapsing if GFR ceases Sop up waste products secreted by the proximal tubule that bind to protein so that my protein transporters and channels continue to function properly
345
The __ __ is the first fluid barrier found between the extracellular subcompartments with a one way lymphatic shunt returning interstitial fluid to the plasma
Capillary membrane
346
The __ __ is the seconda barrier to fluids, separating intracellular from extracellular fluids
Cell membrane
347
Fluid distribution between plasma, interstitial fluid and intracellular
IC>IS>plasma
348
Extracellular Iona
Na Cl HCO3
349
Intracellular ions
K, PO43 protein
350
The kidneys maintain the extracellular __ ion concentrations from which the cells of the body extract their needs
Small
351
Major sources of ions
Liver, lymphocytes
352
Gibbs-donnan equilibrium
Maintains cell volume constant With protein inside the cell and na outside
353
Causes of extracellular edema:increased capillary hydrostatic pressure
Increased capillary hydrostatic pressure Excess kidney retention of salt and water (acute or chronic kidney fail, mineralocorticoid excess) High venous pressure (heart failure, venous obstruction , failure of venous pumps) Decreased arteriolar resistance (excessive body heat, insuffiency of the sympathetic nervous system, vasodilator drugs)
354
Causes of extracellular edema : decreased plasma proteins
Loss of protein (nephrotic syndrome) Loss of protein from denuded skin areas (burns, wounds) Failure to produce proteins (liver disease, severe protein or caloric malnutrition)
355
Causes of extracellular edema : increased capillary permeability
Immune reactions that cause release of histamine, toxins, bacterial infections, vitamin defiency, espicially vitamin C, prolonged ischemia, burns
356
Causes of extracellular edema: blockage of lymph return
Cancer, infections(filariasis, nematodes), surgery, congenital absence or abnormality of lymphatic vessels
357
What prevents extracellular edema
Interstitial normally has low compliance Lymph flow can increase 10-50 fold Increased amounts of protein poor capillary fluid flow wash protein out from the interstitial space, decreasing net capillary filtration pressure
358
What are the two main causes of intracellular edema
Depression of metabolic systems of tissues Lack of adequate nutrition to the cells *cells lack the resources to drive the NaKATPase pump, so Na accumulates in cells and they expand and water follows sodium into the cells
359
Other causes of intracellular edema
Too little extracellular Na or too much water
360
What does high extracellular edema cause
Brain cell swell
361
Are water and Na regulated separately
Yup Na content and concentration are not the same thing
362
Na content
Sensed by effective vascular volume, stretch receptors AngII Aldo SNS ANF
363
H2O
Plasma osmolality Osmoreceptors ADH
364
RBF and GFR are ______ but urinary output of Na and H2) increases as __ increases
Autoregulated | MAP
365
Tubuloglomerular feedback of increased GFR and RBF
Increased delivery of solute to juxtaglomerular apparatus Increased resistance of afferent arterioles Decreased RBF and GFR
366
What happens to creatinine when GFR falls due to ACEI
Creatinine increases This presernves kidney function in hyperfiltering diabetics can also alarm physicians
367
Glomerulotubular balance
Small increase in GFR dueto increased MAP, get increase Pc, ensuring that there is proportional reabsorption of filtrate. More is reabsorbed but more is also delivered to the thin limbs and more reaches the distal portions With volume expansion, dilution of plasma proteins+ increased RBF leads to these changes in the peritubular capillary
368
Countercurrent multiplier
Create gradient of 2 across the transported is multiplied along the length of the transporter array due to countercurrent flow In TAL to provide solute for the hypertonic renal medullary interstitial while simultaneously diluting the tubular fluid
369
Concentrated outflow
Generated hypertonic renal medullary interstitial
370
Dilute outflow
Neededfor the possible excretion of excess water
371
Vascular sensory for circulating volume
Vascular Low pressure-cardiac atria, pulmonary vasculature High pressure-carotid sinus, aortic arch, juxtaglomerular apparatus of kidneys
372
Hormones that effect PT where 67% of reabsorption occurs through NaH exchange, Na cotransport and organic solute, NaH CL anion exchange
Angiotensin II NE E
373
Hormones that regulate the late distal tubules and collecting duct which reabsorbed 3% of load with Na channels
Aldosterone | ANP
374
Low Na intake, hormones
Ability to retain na will become maxed out and arterial pressure then falls to a level where intake=output on the curve
375
High Na intakehoromones
Hormones minimal values and Na dumping hormones are a maximal values, and further increases in Na intake will cause arterial pressure to increase to a value where intake=output
376
What happens with increased ECF volume from increased Na intake
Decreased sympathetic activity, increased ANP, decreased pi, decreased RAAS All leading to increased excretion of Na
377
What does decreased sympathic activity do
Dilation of afferent arterioles Decreased Na reabsorption
378
What does increased ANP do
Constriction of efferent arterioles | Decreased Na reabsorption
379
What does decreased pi cause
Decreased Na reabsorption
380
What does decreased RAAS cause
Decreased reabsorption
381
Signs of hypovolemia
``` Decreased skin tumor Thirst Dry mucous membranes Sunken eyes Oliguria As worsens get tachycardia, hypotension, tachypnea, confusion ```
382
Signs of hypervolemic
Edema, bounding pulse
383
Relative hypovolemia
Decrease ECFV and increase in total body sodium
384
Renal causes of relative hypovolemia
Severe nephrotic syndrome
385
Renal causes of renal absolute hypovolemia
Diuretics, Na wasting tululopathies, genetic or acquired tubulointerstitila disease, Obstructive uropathy/postobstructive diuresis, hormone defiency, hypoaldosteronism, adrenal insuffiency
386
Causes of volume excess
Oliguric acute renal failure, acute glomerulonephritis, severe chronic renal failure, nephrotic, nephrotic syndrome, primary hyperaldosteronism, Cushing, liver disease, conn, gordon, Liddell
387
Hypernatremia levels
Plasma >145
388
Hyponatremia values
<135
389
Calculate plasma osmolality
2xNa in plasma More accurate 2plasma Na+glucose in plasma/18+ BUN plasma/2,8
390
Normal plasma osmolality
285-295
391
Effect of vasopressin
Plasma osmolality up and blood pressure or volume decrease
392
What increased ADH
Increase plasma osmolality Decrease blood volume Decrease blood pressure Nausea, hypoxia Morphine, nicotine, cyclophosphamide
393
What Decreases ADH
Decreased plasma osmolality Increased blood volume Increased blood pressure Alcohol, clonidine, haloperidol
394
What increases thirst
Increased osmolality Decreased blood volume Decreased blood pressure Increased angiotensin II Dry mouth
395
Decrease thirst
Decreased osmolality Increased blood volume Increased blood pressure Decreased angiotensin II Gastric distention
396
Response to drinking water and decrease in plasma osmolality
Inhibits osmoreceptors in anterior hypothalamus—THIRST decreased Decrease ADH Decrease H2O permeability in late distal tubule and CD Decrease H2O reabsorption Decrease urine osmolarity and increase volume Increase plasma osmolarity toward normal
397
Response to water deprivation and increase in plasma osmolarity
Stimulates osmoreceptors in anterior hypo->increase thirst Increase ADH from PP Increase H2O permeability in late DT and CD Increase H2O reabsorption Increase urine osmolarity Decrease urine vol Decrease plasma osmolarity toward normal
398
Volume compartment lose na and H2O Diarrhea
Lose volume from ECF
399
Body compartment: lost H2O Water deprived
Lose volume os ICF and ECF | Increase osmolarity in ICF and ECF
400
Body compartment Lost Na Adrenal insuffiency
Lose volume ECF gain volume ECF lost osmolarity in ICF and ECF
401
Body comparemtn gain na and H2O Infusion of isotonic NaCl
Gain volume in ECF
402
Body compartment gain Na High NaCl intake
Increase volume ECF lose volume ICF | Gain osmolarity in ICF and ECF
403
Body compartment gain H20 SIADH
Gain volume ECF, ICF, lose osmolarity ICF and ECF
404
What is the most common electrolyte abnormality encountered in clinical practice
Hyponatremia <135 mEq/L In 15-20% of hospitalized patients!!!
405
What causes hyponatremia
CHF Liver disease sepsis Nephrotic syndrome Prego
406
Drugs for euvolemic
SIADH
407
SALT LOSS hyponatremia symptoms
``` Stupor/coma Anorexia, nausea, vom Tendon reflexes decreased Limp muscles (weak Orthostatic hypotension Seizures/headache Stomach cramping ```
408
Treat minimal hyponatremia
Fluid restriction
409
Treat moderate symptoms of hyponatremia
Vaptans or hypertonic NaCl
410
Treat severe hyponatremia
Hypertonic NaCl
411
Normonatremia brain
NaKCli and H2O
412
Acute hyponatremia brain
NaKCl and INCREASED H2O
413
Chronic hyponatremia brain
NaKCL and H2O decrease
414
Osmotic demyelination
Increase na and decrease H2O
415
Calculate infusion rate for NaCl 3%
Ptweightxdesired correction rate
416
Overly rapid correction of hyponatremiacan cause what
Osmotic demyelination syndrome Can do 2.5 mEq/L/hr in acute In chonic .5?
417
Causes of SIADH
Desmopressin, oxytocin, NSAIDS, MDMA, tumors producing vasopressin , brain tumors, HIV, traumatic brain injury
418
Hypernatremia common in hospitalized?
1% associated with high mortality and morbidity in the elderly See in people that live alone and fall Indicator of neglect in nursing home Ppl in desert
419
Causes of hypovolemia hypernatremia
Administration of hypertonic saline, hypertonic sodium bicarbonate Hypertonic dialysis Hypertonic feedings Primary hyperaldosteronism Cushing
420
Causes of euvolemic hypernatremia
Diabetes insipidus Hypodipsia Insensible dermal and skin loses
421
Causes if hypovolemia hypernatremia
Lack of access to water broken thirst MOA
422
Mnemonic for hypernatremia symptoms | TRIP
Twitching tremors, hyperreflexia Restlessness, irritable, confusion I intense thirst, dry mouth, decreased urine output Pulmonary and peripheral and peripheral edema
423
Treat hypovolemia hypernatremia
Isotonic saline
424
Treat hypernatremia
Hypotonic IV solutions
425
Calculate water deficit
.6% body weightx (1-140/Na)
426
Why correct hypernatremia slowly
Will cause brain edema Correct over 48 hours at .5mEq/L/hr
427
What keeps ion distribution between ICF and ECF
NaKATPase
428
Define hyperkalemia
>5.3
429
Define hypokalemia
<3.7 mEq/L
430
High K
Cells stay refractory since Na channels are not deactivated High T wave, prolonged PR interval, v fib
431
Low K effect
Hyperpolarized Low T wave High U wave low ST
432
What is the normal K range
3.5-5
433
Academia ICF and H and K
ICF takes in H Low ECF pH<7,35 High H buffered by raising ECFK
434
Alkalemia ICF K and H
ICF donates H so ECF has ph>7.45 Low H, bufferented by lowering ECF K
435
How can too much K cause death
K into ECF could lead to fatal hyperkalemia if not for its rapid redistribution into the ICF; insulin is most important
436
K into ICF hormones Enhance cell uptake
``` Insulin!!!!! B2 agonist Aldosterone defiency A blockers Alkalosis Hypoosmolarity ```
437
K into cell hormones
``` A agonist (NE, EPI) Insulin defiency Aldosterone B2 blockers Acidosis Hyperosmolarity Exercise Lysis ```
438
Aldosterone does what
Increase Na in | K out at principal cells of collecting duct
439
What enhances K secretion if normal or excess potassium
``` Plasma K Aldosterone ADH Acid base balance Tubular fluid flow rate ``` DISTAL NEPHRONNNN
440
Low levels of aldosterone
Limit Na permeability in distal nephron, and without Na influx, do not have K secretion/excretion
441
Increased Na delivery and increased flow rate
Combine to promote increased K secretion/excretion
442
Hypokalemia with what K levels
<3.5
443
Acid base balance normal with hypokalemia
Due to redistribution or extrearenal k losses
444
Acid base metabolic acidosis hypokalemia
With renal or extrarenal K loss
445
Hypokalemia metabolic alkalosis
Love K excretion High Cl excretion -BP normal diuretics -BP high hyperaldosteronism
446
Hyperkalemia with what K level
>5.5
447
Pseudohyperkalemia with hyperkalemia
Due to RBC cell lysis
448
Causes of hypokalemis GRAPHIC IDEA
GI losses (vomit, diarrhea) Renal tubular acidosis (types I and II) Aldosterone Paralysis Hypothermia Insulin excess Cushing Insufficient intake Diuretics Elevated beta adrenergic activity Alkalosis
449
Signs and symptoms of hypokalemia
CNS-drowsi Neuromuscular-weak skeletal and weak smooth (ileus and constipation) CV-ventricular arrhythmias, hypotension, cardiac arrest Renal-impaired concentrating ability causes polyuria and nocturnal Metabolic?
450
Goals of treating hypokalemis
Prevent life threatening conditions Replace K Diagnose/correct underlying cause
451
Hyperkalemia causes RED FETS
Renal disease: ARF, CKD, type iV RTA Excessive intake: food, K+IV fluids, blood transfusion Drugs: K sparing diuretics, K salts of penicillin Fictitious: prolonged use of tourniquet, hemolysis Endocrine: Addison’s Tissue release: rhabdomysis, burns, hemolysis, cytotoxic therapy Shift out of cell: acidosis, B antagonist, insulin defiency, tissue damage
452
Cardiac signs of hyperkalemia
Abnormal heart rhythm, bradycardia, v fib, peaked T wave
453
Neuromuscular signs of hyperkalemia signs and symptoms
Numbnesss, weakness
454
Common causes of hyperkalemia: meds targeting RAAS
NSAIDS, COX2 inhibitors , aliskiren beta blockers ACEI ARBS Spironolactone Amiloride
455
Treat hyperkalemia
Antagonize cardiac effects (IV Calcium) Redistribute K into cells (give insulin and glucose, B2 agonist such as albuterol) Facilitate K elimination (administer K losing diuretic consider mineralocorticoid (if have hypoaldosteronsm , cation exchange resin, dialysis)
456
Pseudohyperkalemia
Hemolysis Thrombocytopenia Leukocytosis
457
Redistribution hyperkalemia
``` Acidosis. Decreased insulin B block Arginine infusion Digitalis overdose Periodic paralysis ```
458
Impaired renal K excretion
GFR<5 mL/mim oliganuria >20 impaired K secretion -low or normal aldosterone
459
Low aldosterone
Addison disease Hyporeniinemic Drugs
460
High aldosterone
Primary tubular disorders | Drugs-spironolactone, amiloride, triamterene
461
UTI can result in what
``` Cystitis Prostatis Pyelonephritis Renal damage in young children Pre term birth Complications from frequent antibiotic use -antibiotic resistance, C diff ```
462
Asymptomatic UTI
Asymptomatic bacteriuria
463
UTI pathophysiology
Contamination of the periurethral area with a uropathogen from the gut Colonization of the urethra and migration to the bladder Colonization and invasion of the bladder, mediated by pili and adhesins Neutrophil invasion Bacterial multiplication and immune system subversion Biofilm formation Epithelial damage by bacterial toxins and proteases Ascension to the kidneys Colonization o the kidneys Host tissue damage by bacterial toxins Bacteraemia
464
Uncomplicated UTI
Acute cystitis or pyelonephritis -likely in nonpregnant outpatient women without an atomic abnormalities or instrumentation of the urinary tract Cystitis Pyelonephritis
465
Complicated UTI
Compromised urinary tract or host defense - urinary obstruction - urinary retention caused by neurological disease - immunosuppression - renal failure - renal transplantation - pregnancy - foreign bodies (calculi, indwelling catheters)
466
Inflammatory response in the bladder and __ accumulation int he catheter
Fibrinogen
467
Most common uncomplicated and complicated uTI pathogens
EPUC | Uropathogenic E. coli
468
UPEC
Biofilm like intracellular bacterial communities Type 1 pili*, antigen 43, curli
469
P. Mirabilis
Produce urease Calcium crystals and magnesium ammonium phosphate precipitates Crystalline biofilm
470
P aeruginosa
Microcolony formation by changing hydrophobicity of P aeruginosa surface Lectins, rhamnolipids
471
E faecalis
Fibrinogen
472
What are the types of UTI
Asymptomatic bacteriuria Cystitis Pyelonephritis Complicated UTIprostatis
473
Symptoms ASB
None
474
Clinical presentation ASB
Urine screen unrelated to GU tract symptoms Bacteriuria
475
Treat ASB
None
476
Cystitis symptoms
Dysuria, urinary frequency, urgency Nocturia, hesitancy, suprapubic discomfort, gross hematuria
477
Clinical presentation cystitis
Likely a young, non pregnant female with above symptoms
478
Treat cystitis
Nitrofurantoin, TMP-SMX, fosfomycin Oral beta lactam (amoxicillin, cefpodoxime, cefdinir, cefadroxil) Fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin)
479
First line cystitis for gram + and - bacteria (P aeruginosa and proteus)
Nitrofurnation
480
MOA nitrofurnation
Not fully understood Conversion of nitrofurantoin into highly reactive intermediates by bacterial reductase Toxic intermediates react nonspecifically with many ribosomal proteins and disrupt synthesis of proteins, RNA, DNA, and metabolic processes
481
Pharmacokinetics nitrofurantoin
Metabolized and excreted so quickly that no systemic antibacterial action is acheived
482
Adverse reactions nitrofurnation
Anorexia, nausea, vomiting Antagonizes nalidixic acid (synthetic quinolone antibiotic)
483
Contraindications nitrofurnation
Glucose 6 phosphate DH defiency Antagonizes nalidixic acid (synthetic quinolone antibiotic)
484
Cystitis first line fosomycin for gram positive and negative bacteria MOA
CELl wall synthesis inhibitor Inhibits the cytoplasmic enzyme enolpyruvate transferase by covalently binding to the cysteine residue of the active site and blocking the addition of phosphoenolpyruvate to UDP-N-acetylglucosamine
485
Resistance for fosofomycin
Due to inadequate transport of drug into the cell
486
Pharmacokinetics fosfomycin
Only oral form approved in USA, oral bioavailability is 40%
487
AE fosfomycin
Limited (headache and diarrhea)
488
CE fosfomycin
Safe in pregnancy!
489
First line for cystitis
Nitrofurnation and fosfomycin TMP-SMX
490
Can you take nitrofurantoin and fosfomycin is suspect early pyelonephritis
No doesn’t achieve adequate renal tissue levels
491
Why should TMP-SMX be avoided
If prevalence of resistance is known to exceed 20%
492
Second line cystitis oral beta lactam
Amoxicillin-aminopenicillin Cefpodoxime-3rd generation cephalosporin Cefdinir-3rd generation ceph Cefadroxil-1st gen cephalosporin Less effective than fluoroquinolones (more side effects) and TMP-SMX
493
Why are fluoroquinolones third line for cystitis
SE
494
Name fluoroquinolones
Ciprofloxacin Levofloxacin Ofloxacin Moxifloxacin is NOT RECOMMENDED bc attains lower urinary levels than other fluoroquinolones
495
FDA warning fluoroquinolones
Disabling and potentially irreversible adverse effects of systemic fluoroquinolones outweighs their benefits in treating uncomplicated cystic Tendinitis and tendon rupture Peripheral neuropathy CNS effects
496
Why not use ampicillin and amoxicillin to empirically treat cystitis
Resistance
497
Resistance to oral antibiotics is rare
Espicially among outpatients with uropathogenic E. coli
498
How treat cystitis if resistance is identified
Ertapenem (a car ape EM)
499
Ertapenem
As a class carbapenems have a wide spectrum with good activity against gram negatives (including p aeruginosa), gram positive, and anaerobes Ertapenem specifically is insufficiently active against P aeruginosa
500
Symptoms of pyelonephritis
Unilateral back or flank pain, fever Mild-low grade fever with or without lower back pain or costovertebral angle pain Severe-high fever, rigors, nausea, vomiting, and flank andor loin pain Development of bacteremia
501
Clinical presentation pyelonephritis
Fever (not present in cystitis), low back pain May or may not have symptoms of cystitis
502
Treat pyelonephritis
Fluoroquinolones (ciprofloxacin, levofloxacin) TMP-SMX, oral beta lactam, aztreonam
503
Fluoroquinolones for first line pyelonephritis
Ciprofloxacin or levofloxacin Give for severe pyelonephritis or risk factors for resistance -administered with parenteral broad spectrum antibiotic until susceptibility data is available Aminoglycosides used are gentamicin and tobramycin
504
What are aminoglycosides gentamicin and tobramycin active against
Gram negative and P aeruginosa
505
MOA aminoglycosides gentamicin and tibramycin
Irreversible protein synthesis inhibitos, binds to 30s ribosomal subunit Interference with the initiation complex of peptide formation Misreading of mRNA leading to production of non functional proteins
506
Pharmacokinetics amioglycosides gentamicin and tobramycin
Cleared by kidneys
507
Adverse effects of aminoglycosides gentamicin and tibramycin
8th CN toxicity: vertigo, hearing loss Renal toxicity Neuromuscular blockade
508
Second line for pyelonephritis
TMP SMX, oral beta lactams, aztreonam
509
When use TMP SMX , oral beta lactams, or aztreonam for pyelonephritis
Fluoroquinolone patient hypersensitivity or fluoroquinolone resistance
510
Name oral beta lactams
Amoxicillin cefpodoxime Cefdinir Cefadroxil
511
What give to pyelonephritis if patient cant tolerate TMP SMX or oral beta lactams
Aztreonam
512
Aztrenonam second line pyelonephritis
Monobactam, monocyclic beta lactam ring
513
What does aztreonam work against
Activity against aerobic gram negatives (P aeruginosa)
514
Why can aztreonam be used in patients with penicillin hypersensitivity
Little cross reactivity with bicycling beta lactams
515
MOA aztreonam
Cell wall synthesis inhibitor, transpeptidase inhibitor
516
Pharmacokinetics aztreonam
IV formulation, 1-2 hour half life, prolonged in renal failure
517
Adverse effects aztreonam
Limited, neutropenia (children 3-11%) , pain at injection (children 12%)
518
Complicated UTI symptoms
Similar to uncomplicated cystitis and pyelonephritis | Can by cystic, pyelonephritis or both
519
Clinical presentation complicated UTI
Severe dysuria | 70-80% of all complicated UTI are due to an indwelling catheter
520
Treat complicated UTI
Organisms causing complicated UTIs are more likely to be resistant to commonly used oral agents recommended for empiric treatment of uncomplicated cystitis
521
Cystitis
Ciprofloxacin or levofloxacin
522
Pyelonephritis (mild)
Ceftriaxone, ciprofloxacin, levofloxacin or azteronam
523
Pyelonephritis severe
Beta lactam and beta lactamase inhibitor or a carabapenem
524
First line for complicated cystitis fluoroquinolones
Ciprofloxacin or levofloxacin Covers p aeruginosa MOXIFLOXACIN is not recommended -attains lower urinary levels than other fluoroquinolones
525
How treat complicated cystitis with presence of gram + cocci on gram stain suggests enterococci UTI (E faecalis, E faecium)
Mpicillin or amoxicillin
526
Poor empiric choices due to high precenalnce of resistance
Nitrofurantoin TMP SMX Fosfomycin Oral beta lactams (amoxicillin, cefpodoxime, cefdinir, cefadroxil) Use these drugs only is uropathogenic is known to be susceptible
527
Phenazopyridine
Urinary analgesic with unknown mechanism, can cause significant nausea Colors urine orange/red
528
First line for complicated (mild ) pyelonephritis
Ceftriaxone, ciprofloxacin or levofloxacin - covers P aeruginosa - moxifloxacin is NOT recommended - attains lower urinary levels than other fluoroquinolones Aztreonam
529
Ascomplicated pyelonephritis first line severe
Cefepime Piperacillin+ tazobactam -if P aeruginosa suspected a higher dose can be used Ceftolozane+tazobactam Ceftazidime+avibactam Meropenem -if p aeruginosa suspected a higher dose can be used Imipenem Doripenem
530
Tazobactam and avibactam
B lactamase inhibtiors
531
How are b lactamase inhibitors given
Piperacillin+tazobactam Ceftolozane+tazobactam Ceftazidime+avibactam
532
What determines tha antibacterial spectrum of b lactamase inhibtiors : tazobactam and avibactam
By companion beta lactam
533
MOA tazobactam and avibactam
Resemble B lactam molecules, very weak antibacterial action Protect hydrolysable B lactams from inactivation by these enzymes ``` Good inhibtors of amber class A B-lactamase -these b lactamase are produced by staphylococci, H influenzae, N gonorrhea, salmonella, shigella, E. coli* and K pneumoniae* ``` ``` Poor inhibtiors of class C b lactamase -these B lactamase are produced by enterobacter app, citrobacter spp, S marcescens, and P aeruginosa ```
534
Adverse effects tazobactam and avibactam
Limited (<10%), diarrhea, constipation, vomiting, skin rash
535
Bacteria that can cause complicated UTI
E. coli, K pneumoniae, enterobacter, P aeruginosa
536
Name carbapenems for complicated pyelonephritis first line
Imipenem, doripenem, meropenem, ertapenem (resistant cystitis)
537
What are carbapenems good against
Wide spectrum with good activity against gram negatives (including p aeruginosa), gram positives, and anaerobes - doripenem and meropenem have greater activity against gram negatives and slightly less activity against gram positives - ertapenem insufficiently active against P aeruginosa
538
Carbapenems are resistant to ___
B lactamases
539
MOA carbapenems
Inhibit transpeptidase, similar to penicillins and cephalosporins
540
Imipenem pharmacokinetics
Metabolized by dihydropeptiase in kidney
541
Doripenem, meropenem, ertapenem
Not metabolized by dihydropeptidase
542
of the carbapenems, ___has the longest half life ( 4 hours), administered with lidocaine to reduce irritation after intramuscular injection
Ertapenem
543
Adverse effects imipenem (more common)
Nausea, vomiting, diarrhea, skin rashes, infusion site reactions, seizures
544
Doripenem, meropenem, ertapenem AE
Less likely to cause seizures
545
Complicated pyelonephritis (severe) first line b lactams
Piperacillin-anti-pseudomonas penicillin Ceftazidime-3rd gen cephalosporincefepime-4th gen cephalosporin Ceftolozane-5th gen ceph
546
Which b lactams are given in combo with a b lactamase inhibtor to extend the spectrum
Piperacillin Ceftazidime Ceftolozane
547
MOA b lactams
Cell wall synthesis inhibitors, bind and inhibit transpeptidase
548
AE complicated pyelonephritis b lactams
B lactam hypersensitivity
549
Prostatic pathogen
E. coli (most), proteus, P aeruginosa Enterobacteriaceae including klebsiella, enterobacter, and seratia spp
550
Symptoms prostatis
Fever, chills, malaise, myalgia, dysuria, lower urinary tract symptoms (frequency, urgency, urge incontinence), pelvic of perineal pain and cloudy urine
551
Clinical presentation prostatis
Patient is acutely ill with spiking fever, possible complaint of pain During the exam, a prostate will be warm, firm, edematous and tender
552
Treat prostatis
TMP SMX Ciprofloxacin Levofloxacin
553
Post streptococcal glomerulonephritis
Most common cause of acute nephritis in kids -97% of cases occur in regions with poor ppl Caused by prior infection with group A beta hemolytic strep(gram+)
554
Clinical presentation post strep glomerulonephritis
Asymptomatic, microscopic hematuria Acute nephritic syndrome (red/brown urine, proteinuria, edema, HTN, elevation in serum creatinine)
555
Treat post strep glomerulonephritis
Management-loop diuretic, anti HTN agent, dialysis Recurrent group A beta hemolytic strep infection -antibiotics
556
Treat recurrent strep
With agents greater B lactamase stability Penicillin G -IM injection if adherence to previous antibiotic uncertain Cephalexin or cefadroxil -1st gen cephalosporins Cefpodoxime or cefdinir -3rd gen cephalosporins Amoxicillin or clindamycin
557
What is clindamycin effective against
Streptococci, staphylococci, and pneumococci - enterococci and gram negative aerobes resistant - very effective against anaerobes
558
MOA clindamycin
Protein synthesis inhibitor, binds 50S ribosomal subunit
559
Pharmacokinetics clindamycin
Penetrates most tissue (not brain and CSF) Metabolized in the liver and excreted int he urine
560
AE clindamycin
Diarrhea, nausea, skin rashes Risk factor for C diff induced diarrhea and colitis -GI filled with anaerobes
561
Case questions
Ok
562
Benign prostatic hyperplasia causes bladder outlet ___
Obstruction
563
Lower urinary tract symptoms
Interrupted stream, frequency, hesitation, fullness, dribbling, urgency, weak stream
564
Moxafloxacin
Don’t pick it-doesn’t go into urine
565
A1 adrenergic receptor antagonists for BPH
Terazosin, doxazosin, tamsulosin, silodosin, alfuzosin
566
What do a1 adrenergic receptors do
Relax muscle tone Rapid relief of symptoms
567
A1_>a1_ for blood vessels vascular resistance
B | A
568
What does prostate smooth muscle contraction
A1A
569
Detruser receptor for instability
A1D>a1A
570
Spinal cord | Control of urinary function
A1D
571
Stimulation of __ receptors mediates lower urinary tract symptoms
A1
572
A1 receptors +NE
Muscle contraction Bladder outlet obstruction
573
A1D receptors and NE
Detruser instability
574
A1 antagonists compete with NE
Reduce spasm Promote muscle relaxation Improve urine flow
575
Terazosin and doxasin specificity
A1>>a2 Take 1 hours prior
576
Terazosin and doxazosin uroselective
No
577
AE terazosin and doxazosin
Postural hypotension, dizziness fatigue
578
Terazosin and doxazosin drug interactions
PDE-5 inhibitors (sildenafil, vardenafil)
579
Tamulosin and silodosin specificity
A1a=a1D>a1B
580
Tamsulosin and silodosin uroselective
Yes | A1a-a1D
581
AE tamsulosin and silodosin
Reduced ejactulation, IFIS
582
Drug interactions tamulosin and silodosin
PDE inhibitors (sildenafil, vardenafil) Increase concentration of CYP3A4
583
Alfuzosin specificity
Non specific | A1 selective
584
Alfuzosin uroselective
Yes (functional)
585
AE alfuzosin AE
QT prolongation
586
Drug interactions alfuzosin
PDE-5 inhibitors (sildenafil, vardenafil) Increase concentration of CYP 3A4 substrates
587
Clinical summary of a1 adrenergic receptor antagonists
- best monotherapy for prompt relief of symptoms (days) - all have comparable clinicalefficacy - alfuzosin has functional uroselectivity - distributes into the prostate>serum - avoid in hepatic impairment - take immediately after the same meal every day Tamsulosin-FDA approved as generic
588
Steroid 5a reductase inhibitors
Finasteride, dutasteride Prevents enlargement and shrinks prostate Delayed action -shrinkage takes 3-6 months
589
Why does the prostate enlarge
Aging+dihydrotestosterone
590
Steroid 5a reductase inhibitors blunt prostate enlargement
Ok
591
What enables prostate epithelium survival and growth
Androgenic steroids, testosterone, and DHT
592
__ is 10times more potent than its precursor
DHT
593
_____ coverts serum T to DHT in cells
Steroid 5a reductase type 1 and type 2
594
A hyperplastic prostate has excess ___
SAR-2
595
DHT starvation causes what
Epithelial atrophy, shrinkage, and gradual relief of LUTS
596
Direct effects of steroid 5a reductase inhibitors
T accumulation DHT depletion
597
Indirect effects of steroid 5a reductase inhibitors
Androgen receptor less occupied No gene transcription
598
Finasteride
Specific inhibitors SAR2
599
Dunasteride
Dual inhibitorSAR1 and 2
600
Finasteride | Selectivity, SAR in BPH, prostate DHT, PSA, serum T, serum DHT
SAR2 SAR2>>1 90% decreased PSA 50% decreased 15-20% increased 70% decreased
601
Dutasteride Selectivity, SAR in BPH, prostate DHT, PSA, serum T, serum DHT
SAR 1 and 2 SAR2>>1 90% decreased 50% decreased 15-20% increased 90% decreased
602
Clinical summary of finasteride and dutasteride
Take 3 months for measurable effect to be observed Have similar efficacy - improved LUTS - reduced prostate volume and reduced serum PSA - reduced need for surgery Have similar AE - erectile dysfunction - gynecomastia - depressed libido - ejaculation disturbance No dosage adjustment necessary for: Age, renal insuffiency No established clinically significant drug interactions Use caution with liver abnormalities -metabolized by hepatic CYP3A
603
Combination therapy: | A1 adrenergic antagonist+5a reductase inhibitor.
For severe symptoms of BPH, known to have large prostate, no response from monotherapy Long term combination therapy significant improves patient symptoms versus either drug alone
604
BPH treat
PDE-5 inhibtors tadalafil | -for patients with both BPH and ED
605
ED
Consistent or recurrent inability to acquire or sustain an erection of sufficient regidity and duration for sexual intercourse
606
Risk factors for ED
Obesity, smoking, stress, CVD, adverse drug effect (diuretics, antidepressants SSRI)
607
Physiology of penile erection
Blood flows into corpora cavernous and corpus spongiosum (glans penis) NO facilitates smooth msucle relaxation - maximize blood flow - penile engorgement Relaxed smooth muscle leads to blood in sinusoids and a rigid organ
608
What does NO lead to
Increase in cGMP, decreases in iCa, smooth muscle relaxation and erection
609
What do PDE-5 inhibitors do
Competitive inhibitors of the PDE-5 enzyme
610
Sildenafil onset, duration, stomach contents, t1/2, clearance
Take 1 hour prior, 4 hours, empty, 4, hepatic CYP3A4
611
Vardenafil onset, duration, stomach contents, t1/2, clearance
Take 1 hour prior, 4-5 hours, empty, 4, hepatic CYP3A4
612
Tadalafil onset, duration, stomach contents, t1/2, clearance
Take 1 hour prior, 36 hours(1 weekend), doesn’t matter, 18, hepatic CYP3A4
613
Avanafil onset , duration, stomach contents, t1/2, clearance
Take 15 min prior (high dose)** Take 30 min prior (normal dose) 4 hours, doesn’t matter, 4 hours, hepatic CYP3A4
614
PDE-5 inhibtors have high specificity for the
PDE-5 enzymes
615
Adverse effects of sildenafil, vardenafil, and avanafil
Blue vision and blurred vision PDE-5 1 fold in corpus cavernosum PDE-6 10 fold in retina
616
PDE-1 80 fold | Vasculature, heart, brain
But little significance
617
PDE-11 800 fold pituitary, testes, heart
Negligible
618
Side effects PDE-5 inhibitors
Reasonably well tolerated PDE-5
619
SE PDE-5 inhibitors
Well tolerated PDE-5 related -headache, dyspepsia, nasal congestion PDE-6 related (sildenafil, vardenafil, and avanafil) -blurred blue vision Specific to tadalafil -back pain, myalgia, limb pain
620
Contraindications PDE-5 inhibitors
* organic nitrates - extreme and dangerous Specific to vardenafil -patient needs to be hemodynamically stable Specific to tadalafil -when used for BPH, concurrent a1 blockers not recommended Specific to sildenafil -concurrent a blockers initiated at lowest recommended dose
621
Second line ED theapies
Vacuum erection devices -try first, l,ess expensive and non invasive Penile injections with alprostadil -prostagladin E1
622
MOA alprostadil
Leads to increase in cAMP, decreases in iCa, smooth muscle relaxation, and erection
623
Adverse effects alprostadil
Prolonged erection (priapism)-medical emergency, need to evacuate clogged blood - can result in permanent corporal fibrosis and ED - 6% of men using intrapenile alprostadil injection (can also occur with PDE-5 inhibitors )
624
Treat priapism from alprostadil
Sympathomimetic (phenylephrine)+aspiration
625
Nephrin thick wall vs thin wall transport
Thick active Thin passive
626
Faconi
PCT Filtered glucose, aa, uric acid, phosphate, and bicarbonate are passed into the urine instead of being absorbed Not considered to be a defect in a specific channel, but a more general defect in the function of the proximal tubules
627
Clinical features faconi
``` Polyuria, polydipsia, hypovolemia Hypophosphatemia rickets Growth failure Type 2 renal tubular acidosis Hypokalemia Hyperchloremia Hypophosphatemia/phosphaturia Glycosuria -recall this also can be caused by the sodium glucose co transporter 2 SGlT2 inhibtors (the gliflozins such as canaglofloxin) -proteinuria/aminoaciduria -hyperuricosuria ```
628
Treat faconi
Treat underlying causes Replace substances water in the urine - HCO3 (can use citrate), phosphate+vitamin D to promote bone growth - if genetic causes, minimize intake of substance that is not handled properly (cysteine, tyrosine, galactose, copper)
629
Inherited salt losing renal tubulopathies
Bartter syndrome type I Bartter syndrome type II Barter syndrome III Bartter syndrome type IV Bartter syndrome IVB Bartter syndrome type V Gitelman Syndrome
630
Bartter
Concentrating capacity reduced and diluting capacity reduced
631
Gitelman
Concentrating capacity normal.near normal and diluting capacity reduced
632
Barter syndrome
Dysfunction inNKCC2 , ROMK, CLC-kB ,CLC-Ka
633
Classic bartter type 3
CLCNKB gene | Defect in Cl channel
634
Inheritance bartter
AR Rare Presents in childhood
635
Neonatal bartter
Seen 24-30 weeksof gestation as polyhydramnios;polyuria/polydipsia with hypercalcuria after birth
636
Classic bartter
No noticeable symptoms until school agi - polyuria/polydipsia - vomiting, growth retardation
637
Symptoms of bartter are identical to those taking what
Loop diuretics
638
Treat barrett
Life long increases in dietary Na and K and K sparing diuretics to limit K loss -also PGE2 directly stimulates renin release from juxtaglomerular cells and contributes to the electrolyte abnormalities that are seen in bartter syndrome..NSAIDS can help correct this
639
Symptoms of bartter (like loop diuretics)
Normal to low BP Polyuria/polydipsia Elevated plasma renin and aldosterone Hypokalemia Hyponatremia Hypocalcemia Hypomagnesia Hypochloremic alkalosis Hyperglycemia Hyperuricemia Increased cholesterol and triglycerides ISOTONIC URINE
640
Gitelman syndrome
Defect in. NaCl symporter-defective in gitelman syndrome
641
Inheritance Gitelman
AR less rare than bartter Mutations in the gene coding for the thiazide sensitive NaCl cotransporter in distal tube
642
Presentation gitelman
Late childhood or adulthood, may be more severe in females Mimics chronic use of thiazide diuretics May get htn at later stage
643
Symptoms gitelman
``` Polyuria/polydipsia Hypokalemia Hyponatremia Hypercalcemia Hypomagnesemia Hypochloremic metabolic alkalosis Hyperglycemia Hyperuricemia Increased cholesterol and triglycerides ``` And can DILUTE OR CONCENTRATE URINE
644
Treat gitelman syndrome
Life long Cornerstone is taking NaCL to avoid sodium depletion (which would increase Aldo) and providing supplementation of K and Mg -but supplementation->side effects Aim for asymptomatic stable hypokalemia and borderline hypomagnesemia -an aldosterone antagonist can stabilize the hypokalemia, but it competes with compensatory secondary hyperaldosteronism NSAIDS are ineffective in gitelman syndrome (defect is downstream from macula densa)
645
Gitelman is more __ than bartter
Benign
646
Diagnosis bartter or gitelman
Exclusion Made in someone who presented with unexplained hypokalemia and metabolic alkalosis with a moral or low bp
647
Urine in bartter and gitelman
Gitelman-dilute Bartter-isotonic
648
Calcemia/calciuria in bartter and gitelman
Bartter-hypocalcemia/hypercalciuria, opposite of gitelman
649
In bartter/gitelman urine __ concentration is typically greater than 25 mEq/L despite volume contraction
Chloride Patients who secretively take diuretics have a variable urine chloride concentration correlations with or without diuretic effect..so a urine diuretic screen should be obtained
650
Failure to respond to loop or thiazide diuretics appropriately can aid in diagnosis of _ and _, respectively
Bartter | Gitelman
651
Liddle syndrome
ENaC channel doesn’t degrade properly
652
Inheritance liddle (pseudoaldosteronism)
Rare AD Mutation changes ENaC Chen also so that they are not degraded correctly by ubiquitin proteasome system->increased Na reabsorption with K loss —early and often severe hypertension associated with -low plasma renin activity, low aldosterone -metabolic alkalosis -hypokalemia
653
Treat liddle
Low Na diet and K sparing diuretics
654
Pseudohypoaldosteronism
Caused by a failure of response to aldosterone, leading to renal tubular acidosis and hyperkalemialevevls of aldosterone are actually elevated due to a lack of feedback inhibition
655
Therapy pseudohypoaldosteronism
Large amounts of Na
656
Renal tubular acidosis
Due to unmeasured anions (anion gap) Normal 8-16 mEq/L
657
Type 2 renal tubular acidosis
Renal loss of HCO3(cant reabsorbed) Normal anion gap Hyperchloremia
658
Type 1 renal tubular acidosis
Decrease excretion of H as titratable acid and HN4 Decrease ability to acidity urine Normal anion gap
659
Type 4 renal tubular acidosis
Hypoaldosteronism Decreased excretion of NH4 Hyperkalemia inhibits NH3 synthesis Normal anion gap
660
Renal tubular acidosis
Acidemia, normal anion gap, normal serum creatinine, no diarrhea
661
Type 1 renal tubular acidosis
Distal Impaired H secretion <15 HCO3 Urine pH>5.5 Low K Autoimmune disorder related Severe
662
Renal tubular acidosis 2
Proximal tubule Impaired proximal HCO3 reabsorption Plasma HCO3 12-20 Ph urine under 5.5, over 7 when give alkali therapy Los plasma K Related to faconi, multiple myeloma, drugs
663
RTA3
Combo of 1 and 2, very rare genetic form (carbonic anhydrase II defiency)
664
RTA4
ADRENAL Hyperkalemia Lack of Aldo or failure of kidney to respond to it Plasma HCO3>17 Urine pH <5.5 High plasma K Related to diabetic nephropathy, drugs (ACEI, ARB, heparin, NSAIDS) Normal anion
665
Renal tubular acidosis
Accumulation of acid in the body due to a failure if the kidneys to properly acidity the urine
666
Type 1 RTA
H secretion by a intercalated cells is somehow impaired Recall this is how new HCO3 is generated to maintain acid base homeostasis Phosphate and ammonia buffer this H
667
Treat renal tubular acidosis type 1 (major consequence is low blood K, leading to extreme weakness, irregular heartbeat, paralysis)
Untreated->growth retardation in kids, progressive kidney and bone disease in adults Restore normal growth and preventing kidney stones are the major goals of therapy - sodium bicarbonate or sodium citrate to treat acidosis (1-2 mEq/kg/day) - >correction of low k, salt depletion and Ca leakage..without Ca leakage, also decrease kidney stone development
668
Type 2 RTA
HCO3, the major buffer in the body, is among the good stuff normally reclaimed by the proximal tubules
669
Treat renal tubular acidosis type 2 (PT HCO3 wasting, very rare, often part of faconi)
Identify the correcting the underlying causes of acquired forms of proximal RTA Children with this disorder would likely receive large doses of potassium citrate, and oral alkali (10-15 mEq/kg/day) - correcting acidosis and low potassium levels restores normal growth patterns, allowing bone to mature while preventing further renal disease - vitamin D supplements may also be needed to help prevent bone problems
670
Type 4 RTA
Low Aldo High K Low NH3 synthesis by pT Recall how new HCO3 is generated by having NH3 accept H->NH4 to maintain acid base homeostasis
671
Treat renal tubular acidosis
Type 4 (most common; hyperkalemia from no Aldo or failure to respond to it) - patients may require alkaline agents to correct acidosis, but therapy is aimed primarily at reducing serum K - low K diet and a loop diuretic - alter drug doses and/or change drugs (spironolactone, ACE inhibitors, angiotensin receptor blockers, NSAIDS)